2-weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial

✍ Scribed by Kellokumpu-Lehtinen, Pirkko-Liisa; Harmenberg, Ulrika; Joensuu, Timo; McDermott, Ray; Hervonen, Petteri; Ginman, Claes; Luukkaa, Marjaana; Nyandoto, Paul; Hemminki, Akseli; Nilsson, Sten; McCaffrey, John; Asola, Raija; Turpeenniemi-Hujanen, Taina; Laestadius, Fredrik; Tasmuth, Tiina; Sandberg, Katinka; Keane, Maccon; Lehtinen, Ilari; Luukkaala, Tiina; Joensuu, Heikki

• Book ID: 121336884
• Publisher: The Lancet
• Year: 2013
• Tongue: English
• Weight: 206 KB
• Volume: 14
• Category: Article
• ISSN: 1470-2045
• DOI: 10.1016/S1470-2045(12)70537-5